Ablation for atrial fibrillation: can we decrease thromboembolism without increasing the risk for bleeding?
Samuel J
SJ
Asirvatham
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000628:therapy*; D017115:Catheter Ablation / Q000009:adverse effects* / Q000379:methods*; D016903:Drug Monitoring / Q000379:methods; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D020521:Stroke / Q000209:etiology / Q000517:prevention & control; D013923:Thromboembolism / Q000150:complications / Q000209:etiology / Q000517:prevention & control*
D000925:Anticoagulants